Qigong Institute

Author: Danciu M¹, Alexa-Stratulat T², Stefanescu C³, Dodi G⁴, Tamba BI⁵, Mihai CT⁶, Stanciu GD⁷, Luca A⁸, Spiridon IA⁹, Ungureanu LB¹⁰, Ianole V¹¹, Ciortescu I¹², Mihai C¹³, Stefanescu G¹⁴, Chirilă I¹⁵, Ciobanu R¹⁶, Drug VL¹⁷
Affiliation:
¹Pathology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. mihai.danciu@umfiasi.ro.
²Medical Oncology-Radiotherapy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. teodora.alexa-stratulat@umfiasi.ro.
³Department of Biophysics and Medical Physics-Nuclear Medicine, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. cipriana.stefanescu@umfiasi.ro.
⁴Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. gianina.dodi@umfiasi.ro.
⁵Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. bogdan.tamba@umfiasi.ro.
⁶Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. cosmin-teodor.mihai@umfiasi.ro.
⁷Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. gabriela-dumitrita.s@umfiasi.ro.
⁸Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. andrei.g.luca@umfiasi.ro.
⁹Pathology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. irenespiridon@yahoo.com.
¹⁰Pathology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. loredana.ungureanu81@gmail.com.
¹¹Pathology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. ianole.victor@gmail.com.
¹²Gastroenterology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. irinaciortescu@yahoo.com.
¹³Gastroenterology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. catalinamihai@yahoo.com.
¹⁴Gastroenterology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. gabriela.stefanescu@gmail.com.
¹⁵Environmental Health, National Institute of Public Health, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. chirilaioan@yahoo.com.
¹⁶Electrical Engineering Faculty, Gheorghe Asachi Technical University of Iasi, 700050 Iasi, Romania. rciobanu@yahoo.com.
¹⁷Gastroenterology Department, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 700051 Iasi, Romania. vasidrug@email.com.
Conference/Journal: Materials (Basel).
Date published: 2019 May 9
Other: Volume ID: 12 , Issue ID: 9 , Special Notes: doi: 10.3390/ma12091519. , Word Count: 230

The Terahertz's wavelength is located between the microwave and the infrared region of the electromagnetic spectrum. Because it is non-ionizing and non-invasive, Terahertz (THz)-based detection represents a very attractive tool for repeated assessments, patient monitoring, and follow-up. Cancer acts as the second leading cause of death in many regions, and current predictions estimate a continuous increasing trend. Of all types of tumors, digestive cancers represent an important percentage and their incidence is expected to increase more rapidly than other tumor types due to unhealthy lifestyle habits. Because it can precisely differentiate between different types of molecules, depending on water content, the information obtained through THz-based scanning could have several uses in the management of cancer patients and, more importantly, in the early detection of different solid tumors. The purpose of this manuscript is to offer a comprehensive overview of current data available on THz-based detection for digestive cancers. It summarizes the characteristics of THz waves and their interaction with tissues and subsequently presents available THz-based technologies (THz spectroscopy, THz-tomography, and THZ-endoscope) and their potential for future clinical use. The third part of the review is focused on highlighting current in vitro and in vivo research progress in the field, for identifying specific digestive cancers known as oral, esophageal, gastric, colonic, hepatic, and pancreatic tumors.

KEYWORDS: cancer diagnosis; digestive cancer; screening; terahertz endoscopy; terahertz spectroscopy; terahertz tomography

PMID: 31075912 DOI: 10.3390/ma12091519

Qigong and Energy Medicine Database™

Terahertz Spectroscopy and Imaging: A Cutting-Edge Method for Diagnosing Digestive Cancers.